Research progress of pathomics in head and neck neoplasms

doi:10.3760/cma.j.cn371439-20230111-00059

Abstract

Abstract:

Pathomics， the integration of digital pathology and artificial intelligence， is used to assess tumor diagnosis， treatment and prognosis by extracting， screening and analyzing the data features contained in pathological pictures. In recent years， more and more pathomics studies of head and neck neoplasms have shown great value in the areas of computer-assisted diagnosis， tumor microenvironment and biomarker identification as well as prognosis evaluation. It is expected to play an important role in clinical assistance and precise treatment of head and neck neoplasms in the future.

Key words: Head and neck neoplasms, Diagnosis, Prognosis, Pathomics

Ju Yifan, Xu Chenyang, Lei Dapeng. Research progress of pathomics in head and neck neoplasms[J]. Journal of International Oncology, 2023, 50(5): 294-298.

References 37

[1]	Pisani P, Airoldi M, Allais A, et al. Metastatic disease in head & neck oncology[J]. Acta Otorhinolaryngol Ital, 2020, 40(SUPPL. 1): S1-S86. DOI: 10.14639/0392-100X-suppl.1-40-2020. doi: 10.14639/0392-100X-suppl.1-40-2020
[2]	Meccariello G, Maniaci A, Bianchi G, et al. Neck dissection and trans oral robotic surgery for oropharyngeal squamous cell carcinoma[J]. Auris Nasus Larynx, 2022, 49(1): 117-125. DOI: 10.1016/j.anl.2021.05.007. doi: 10.1016/j.anl.2021.05.007
[3]	Chi AC, Katabi N, Chen HS, et al. Interobserver variation among pathologists in evaluating perineural invasion for oral squamous cell carcinoma[J]. Head Neck Pathol, 2016, 10(4): 451-464. DOI: 10.1007/s12105-016-0722-9. doi: 10.1007/s12105-016-0722-9 pmid: 27140176
[4]	Elmore JG, Longton GM, Carney PA, et al. Diagnostic concordance among pathologists interpreting breast biopsy specimens[J]. JAMA, 2015, 313(11): 1122-1132. DOI: 10.1001/jama.2015.1405. doi: 10.1001/jama.2015.1405 pmid: 25781441
[5]	Niazi MKK, Parwani AV, Gurcan MN. Digital pathology and artificial intelligence[J]. Lancet Oncol, 2019, 20(5): e253-e261. DOI: 10.1016/S1470-2045(19)30154-8. doi: 10.1016/S1470-2045(19)30154-8
[6]	Bera K, Schalper KA, Rimm DL, et al. Artificial intelligence in digital pathology—new tools for diagnosis and precision oncology[J]. Nat Rev Clin Oncol, 2019, 16(11): 703-715. DOI: 10.1038/s41571-019-0252-y. doi: 10.1038/s41571-019-0252-y
[7]	Prewitt JM, Mendelsohn ML. The analysis of cell images[J]. Ann N Y Acad Sci, 1966, 128(3): 1035-1053. DOI: 10.1111/j.1749-6632.1965.tb11715.x. doi: 10.1111/j.1749-6632.1965.tb11715.x
[8]	Wright AM, Smith D, Dhurandhar B, et al. Digital slide imaging in cervicovaginal cytology: a pilot study[J]. Arch Pathol Lab Med, 2013, 137(5): 618-624. DOI: 10.5858/arpa.2012-0430-OA. doi: 10.5858/arpa.2012-0430-OA pmid: 22970841
[9]	Wang S, Yang DM, Rong R, et al. Pathology image analysis using segmentation deep learning algorithms[J]. Am J Pathol, 2019, 189(9): 1686-1698. DOI: 10.1016/j.ajpath.2019.05.007. doi: S0002-9440(18)31121-0 pmid: 31199919
[10]	Jacques SL. Optical properties of biological tissues: a review[J]. Phys Med Biol, 2013, 58(11): R37-R61. DOI: 10.1088/0031-9155/58/11/R37. doi: 10.1088/0031-9155/58/11/R37
[11]	Lu G, Fei B. Medical hyperspectral imaging: a review[J]. J Biomed Opt, 2014, 19(1): 10901. DOI: 10.1117/1.JBO.19.1.010901. doi: 10.1117/1.JBO.19.1.010901 pmid: 24441941
[12]	Manolakis D, Shaw G. Detection algorithms for hyperspectral ima-ging applications[J]. IEEE Signal Process Mag, 2002, 19(1): 29-43. DOI: 10.1109/79.974724. doi: 10.1109/79.974724
[13]	Lu S, Stein JE, Rimm DL, et al. Comparison of biomarker modalities for predicting response to PD-1/PD-L1 checkpoint blockade: a systematic review and meta-analysis[J]. JAMA Oncol, 2019, 5(8): 1195-1204. DOI: 10.1001/jamaoncol.2019.1549. doi: 10.1001/jamaoncol.2019.1549
[14]	Bodenmiller B. Multiplexed epitope-based tissue imaging for disco-very and healthcare applications[J]. Cell Syst, 2016, 2(4): 225-238. DOI: 10.1016/j.cels.2016.03.008. doi: 10.1016/j.cels.2016.03.008 pmid: 27135535
[15]	Mansoor I, Zalles C, Zahid F, et al. Fine-needle aspiration of folli-cular adenoma versus parathyroid adenoma: the utility of multis-pectral imaging in differentiating lesions with subtle cyto-morphologic differences[J]. Cancer, 2008, 114(1): 22-26. DOI: 10.1002/cncr.23252. doi: 10.1002/cncr.23252
[16]	Halicek M, Little JV, Wang X, et al. Optical biopsy of head and neck cancer using hyperspectral imaging and convolutional neural networks[J]. J Biomed Opt, 2019, 24(3): 1-9. DOI: 10.1117/1.JBO.24.3.036007. doi: 10.1117/1.JBO.24.3.036007 pmid: 30891966
[17]	Baik J, Ye Q, Zhang L, et al. Automated classification of oral premalignant lesions using image cytometry and Random Forests-based algorithms[J]. Cell Oncol (Dordr), 2014, 37(3): 193-202. DOI: 10.1007/s13402-014-0172-x. doi: 10.1007/s13402-014-0172-x
[18]	Wang Y, Guan Q, Lao I, et al. Using deep convolutional neural networks for multi-classification of thyroid tumor by histopathology: a large-scale pilot study[J]. Ann Transl Med, 2019, 7(18): 468. DOI: 10.21037/atm.2019.08.54. doi: 10.21037/atm.2019.08.54 pmid: 31700904
[19]	Araújo T, Aresta G, Castro E, et al. Classification of breast cancer histology images using Convolutional Neural Networks[J]. PLoS One, 2017, 12(6): e0177544. DOI: 10.1371/journal.pone.0177544. doi: 10.1371/journal.pone.0177544
[20]	Han Z, Wei B, Zheng Y, et al. Breast cancer multi-classification from histopathological images with structured deep learning model[J]. Sci Rep, 2017, 7(1): 4172. DOI: 10.1038/s41598-017-04075-z. doi: 10.1038/s41598-017-04075-z pmid: 28646155
[21]	Ringash J. Survivorship and quality of life in head and neck cancer[J]. J Clin Oncol, 2015, 33(29): 3322-3327. DOI: 10.1200/JCO.2015.61.4115. doi: 10.1200/JCO.2015.61.4115 pmid: 26351336
[22]	Lu G, Little JV, Wang X, et al. Detection of head and neck cancer in surgical specimens using quantitative hyperspectral imaging[J]. Clin Cancer Res, 2017, 23(18): 5426-5436. DOI: 10.1158/1078-0432.CCR-17-0906. doi: 10.1158/1078-0432.CCR-17-0906 pmid: 28611203
[23]	Halicek M, Dormer JD, Little JV, et al. Hyperspectral imaging of head and neck squamous cell carcinoma for cancer margin detection in surgical specimens from 102 patients using deep learning[J]. Cancers (Basel), 2019, 11(9): 1367. DOI: 10.3390/cancers11091367. doi: 10.3390/cancers11091367
[24]	Labani-Motlagh A, Ashja-Mahdavi M, Loskog A. The tumor micro-environment: a milieu hindering and obstructing antitumor immune responses[J]. Front Immunol, 2020, 11: 940. DOI: 10.3389/fimmu.2020.00940. doi: 10.3389/fimmu.2020.00940 pmid: 32499786
[25]	Tong CC, Kao J, Sikora AG. Recognizing and reversing the im-munosuppressive tumor microenvironment of head and neck cancer[J]. Immunol Res, 2012, 54(1/3): 266-274. DOI: 10.1007/s12026-012-8306-6. doi: 10.1007/s12026-012-8306-6
[26]	Wondergem NE, Nauta IH, Muijlwijk T, et al. The immune micro-environment in head and neck squamous cell carcinoma: on subsets and subsites[J]. Curr Oncol Rep, 2020, 22(8): 81. DOI: 10.1007/s11912-020-00938-3. doi: 10.1007/s11912-020-00938-3 pmid: 32602047
[27]	Peled M, Onn A, Herbst RS. Tumor-infiltrating lymphocytes-location for prognostic evaluation[J]. Clin Cancer Res, 2019, 25(5): 1449-1451. DOI: 10.1158/1078-0432.CCR-18-3803. doi: 10.1158/1078-0432.CCR-18-3803 pmid: 30567833
[28]	Hartman DJ, Ahmad F, Ferris RL, et al. Utility of CD8 score by automated quantitative image analysis in head and neck squamous cell carcinoma[J]. Oral Oncol, 2018, 86: 278-287. DOI: 10.1016/j.oraloncology.2018.10.005. doi: S1368-8375(18)30358-0 pmid: 30409313
[29]	Shaban M, Khurram SA, Fraz MM, et al. A novel digital score for abundance of tumour infiltrating lymphocytes predicts disease free survival in oral squamous cell carcinoma[J]. Sci Rep, 2019, 9(1): 13341. DOI: 10.1038/s41598-019-49710-z. doi: 10.1038/s41598-019-49710-z pmid: 31527658
[30]	Shaban M, Raza SEA, Hassan M, et al. A digital score of tumour-associated stroma infiltrating lymphocytes predicts survival in head and neck squamous cell carcinoma[J]. J Pathol, 2022, 256(2): 174-185. DOI: 10.1002/path.5819. doi: 10.1002/path.5819
[31]	Fraz MM, Khurram SA, Graham S, et al. FABnet: feature attention-based network for simultaneous segmentation of microvessels and nerves in routine histology images of oral cancer[J]. Neural Comput Appl, 2020, 32(14): 9915-9928. DOI: 10.1007/s00521-019-04516-y. doi: 10.1007/s00521-019-04516-y
[32]	Das DK, Bose S, Maiti AK, et al. Automatic identification of clinically relevant regions from oral tissue histological images for oral squamous cell carcinoma diagnosis[J]. Tissue Cell, 2018, 53: 111-119. DOI: 10.1016/j.tice.2018.06.004. doi: S0040-8166(18)30113-7 pmid: 30060821
[33]	Cyll K, Ersvær E, Vlatkovic L, et al. Tumour heterogeneity poses a significant challenge to cancer biomarker research[J]. Br J Cancer, 2017, 117(3): 367-375. DOI: 10.1038/bjc.2017.171. doi: 10.1038/bjc.2017.171
[34]	de Ruiter EJ, de Roest RH, Brakenhoff RH, et al. Digital pathology-aided assessment of tumor-infiltrating T lymphocytes in advanced stage, HPV-negative head and neck tumors[J]. Cancer Immunol Immunother, 2020, 69(4): 581-591. DOI: 10.1007/s00262-020-02481-3. doi: 10.1007/s00262-020-02481-3 pmid: 31980916
[35]	Humphries MP, Craig SG, Kacprzyk R, et al. The adaptive immune and immune checkpoint landscape of neoadjuvant treated esophageal adenocarcinoma using digital pathology quantitation[J]. BMC Cancer, 2020, 20(1): 500. DOI: 10.1186/s12885-020-06987-y. doi: 10.1186/s12885-020-06987-y pmid: 32487090
[36]	Janowczyk A, Madabhushi A. Deep learning for digital pathology image analysis: a comprehensive tutorial with selected use cases[J]. J Pathol Inform, 2016, 7: 29. DOI: 10.4103/2153-3539.186902. doi: 10.4103/2153-3539.186902 pmid: 27563488
[37]	Rudin C. Stop explaining black box machine learning models for high stakes decisions and use interpretable models instead[J]. Nat Mach Intell, 2019, 1(5): 206-215. DOI: 10.1038/s42256-019-0048-x. doi: 10.1038/s42256-019-0048-x pmid: 35603010